Sailaja Puttagunta
Chief Tech/Sci/R&D Officer en ITERUM THERAPEUTICS PLC .
Fortuna: 15 968 $ al 31/03/2024
Cargos activos de Sailaja Puttagunta
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ITERUM THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 13/12/2021 | - |
Historial de carrera de Sailaja Puttagunta
Antiguos cargos conocidos de Sailaja Puttagunta.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BIOMX INC. | Chief Tech/Sci/R&D Officer | 28/10/2019 | 13/12/2021 |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Chief Tech/Sci/R&D Officer | 01/12/2018 | 01/10/2019 |
ITERUM THERAPEUTICS PLC | Corporate Officer/Principal | 01/01/2016 | 01/12/2018 |
ALLERGAN PLC | Chief Tech/Sci/R&D Officer | 01/01/2015 | 01/01/2016 |
DURATA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01/06/2012 | 01/12/2014 |
Formación de Sailaja Puttagunta.
Gandhi Medical College & Hospital | Undergraduate Degree |
New York University School of Medicine | Graduate Degree |
Estadísticas
Internacional
Irlanda | 3 |
Israel | 3 |
Estados Unidos | 3 |
Operativa
Chief Tech/Sci/R&D Officer | 5 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ITERUM THERAPEUTICS PLC | Health Technology |
BIOMX INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
Durata Therapeutics, Inc.
Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Sailaja Puttagunta
- Experiencia